Showing results (191-200 of 243) with videos related to
Sort By:
Pageof 25
Journal of Thrombosis and Haemostasis : JTH|January 19, 2021
Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: Update of the guidelines for lupus anticoagulant detection and interpretationKatrien M J Devreese, Philip G de Groot, Bas de Laat, et al.Pharmacogenetics and Genomics|January 21, 2006
Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-AmericansHarumi Takahashi, Grant R Wilkinson, Edith A Nutescu, et al.International Journal of Cardiology|October 25, 2021
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registryArturo Cesaro, Felice Gragnano, Paolo Calabrò, et al.Plos One|December 29, 2015
A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naïve Patients with Non-Valvular Atrial FibrillationVittorio Pengo, Carlo-Federico Zambon, Paola Fogar, et al.Frontiers in Immunology|September 3, 2019
Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 PregnanciesMaria-Grazia Lazzaroni, Micaela Fredi, Laura Andreoli, et al.Journal of Thrombosis and Haemostasis : JTH|October 31, 2020
Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closureVittorio Pengo, Ariela Hoxha, Laura Andreoli, et al.Internal and Emergency Medicine|June 20, 2020
Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registryFelice Gragnano, Elisabetta Moscarella, Paolo Calabrò, et al.Nature Reviews. Cardiology|September 26, 2018
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugsGiuseppe Patti, Ilaria Cavallari, Felicita Andreotti, et al.Rheumatology (Oxford, England)|June 10, 2011
Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control studyAmelia Ruffatti, Marta Tonello, Maria S Visentin, et al.Journal of the American College of Cardiology|November 3, 2022
Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized TrialsCandrika D Khairani, Antoine Bejjani, Gregory Piazza, et al.Pageof 25